Page last updated: 2024-10-18

dalteparin and Cancer of Rectum

dalteparin has been researched along with Cancer of Rectum in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Treatment of a patient with carcinoid metastases in the liver is discussed."1.31Targeted chemoembolization of tumors with poly(2-hydroxyethyl methacrylate) particles. ( Adamyan, A; Gumargalieva, K; Guseinov, E; Horák, D; Kokov, L; Skuba, N; Tchjao, A; Titova, M; Trostenyuk, N; Tsvirkun, V; Vishnevskii, V, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horák, D1
Guseinov, E1
Vishnevskii, V1
Adamyan, A1
Kokov, L1
Tsvirkun, V1
Tchjao, A1
Titova, M1
Skuba, N1
Trostenyuk, N1
Gumargalieva, K1

Other Studies

1 other study available for dalteparin and Cancer of Rectum

ArticleYear
Targeted chemoembolization of tumors with poly(2-hydroxyethyl methacrylate) particles.
    Journal of biomedical materials research, 2000, Volume: 51, Issue:2

    Topics: Anticoagulants; Carcinoid Tumor; Chemoembolization, Therapeutic; Colonic Neoplasms; Dalteparin; Doxo

2000